Sign Out
VAXNEUVANCE is indicated for active immunization for the prevention of invasive disease, pneumonia and acute otitis media caused by Streptococcus pneumoniae serotypes 1, 3, 4,5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F and 33F in infants, children and adolescents from 6 weeks to less than 18 years of age.
VAXNEUVANCE is indicated for active immunization for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V,14, 18C, 19A, 19F, 22F, 23F and 33F in individuals 18 years of age and older.
VAXNEUVANCE may not prevent disease caused by S. pneumoniae serotypes that are not contained in the vaccine.
The use of this vaccine should be in accordance with official recommendations.
